Growth Metrics

Cellectis (CLLS) EBITDA Margin (QoQ) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Cellectis 20.83 Bn 20.62 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -29,918.00
Dec 31, 2025 -15,932.00
Sep 30, 2025 8,018.00
Jun 30, 2025 7,576.00
Mar 31, 2025 -8,079.00
Dec 31, 2024 1,419.00
Sep 30, 2024 14,703.00
Jun 30, 2024 24,793.00
Mar 31, 2024 999,050.00
Dec 31, 2023 288,419.00
Sep 30, 2023 -6,590.00
Jun 30, 2023 358,661.00
Mar 31, 2023 -1.68 Mn
Dec 31, 2022 1.56 Mn
Sep 30, 2022 -1.35 Mn
Jun 30, 2022 -33,431.00
Mar 31, 2022 -168,063.00
Dec 31, 2021 43,492.00
Sep 30, 2021 -17,435.00
Jun 30, 2021 -25,761.00
Mar 31, 2021 20,918.00
Dec 31, 2020 18,811.00
Sep 30, 2020 66,396.00
Jun 30, 2020 -116,775.00
Mar 31, 2020 89,909.00
Dec 31, 2019 -55,632.00
Sep 30, 2019 273,511.00
Jun 30, 2019 -81,757.00
Mar 31, 2019 79,168.00
Dec 31, 2018 16,704.00
Sep 30, 2018 -276,058.00
Jun 30, 2018 -1,742.00
Mar 31, 2018 -1,052.00
Dec 31, 2017 1,808.00
Sep 30, 2017 -11,440.00
Jun 30, 2017 -1,220.00
Mar 31, 2017 -4,538.00
Dec 31, 2016 -13,339.00
Sep 30, 2016 156,358.00
Jun 30, 2016 -138,558.00
Mar 31, 2016 -29,613.00
Dec 31, 2015 18,059.00
Sep 30, 2015 -1,146.00
Jun 30, 2015 -12,326.00